Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Join us for a closer look at tirzepatide, a first-in-class glucose-dependent insulinotropic peptide (GIP) and a glucagon-like peptide-1 receptor agonist (GLP-1 RA). See how this novel glucose-lowering agent can help raise the bar in both HbA1c lowering and weight loss in patients with type 2 diabetes mellitus.

Episode resource links:

• Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 May 17:1–11.

Guest: Alan Ehrlich MD, FAAFP

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Most primary care clinicians treating patients with male androgenetic alopecia are unfamiliar with studies looking at off-label use of medications for this condition. In this episode, you will hear a review of an important recent meta-analysis published in JAMA Dermatology that highlights the efficacy of commonly used agents to treat this condition.

Episode resource links:

• JAMA Dermatol. doi:10.1001/jamadermatol.2021.5743

Guest: Robert A. Baldor MD, FAAFP

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Listen to this podcast to hear a simple method to help those with COPD improve their symptom control and lower exacerbation rates. 

Episode resource links:

• Am J Respir Crit Care Med Vol 205, Iss 4, pp 421–430, Feb 15, 2022

Guest: Jillian Joseph, MSPAS, PA-C

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/migraine-and-cardiovascular-disease-case

Overview:

This podcast will focus on the case of a patient with a long history of periodic migraine attacks whose previously preferred acute medication is now contraindicated because of a recently acquired comorbid condition. Faculty will consider newer medication options for this patient that will take into account his employment requirements and individual preferences, as well as his medical history.

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/your-questions-about-migraine

Overview:

In this podcast, Dr. Dawn Buse will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include deciding when imaging is appropriate in the evaluation of headache, distinguishing between migraine and cluster headache, determining which patients would benefit from preventive migraine therapy, considering how long to use a preventive therapy before determining it to be ineffective, managing menstrual migraines, and treating migraine in children and adolescents.

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Monkeypox is endemic in certain parts of Africa, but outbreaks in Europe and North America have recently occurred. While still uncommon, clinicians need to be alert to the possibility of this diagnosis. This podcast gives you the tools you need to identify risk factors and distinguish the disease from other infections.

Episode resource links:

World Health Organization Health Topics/Monkeypox https://www.who.int/health-topics/monkeypox#tab=tab_1

Disease outbreak New/Item/Multi-country monkeypox outbreak: situation update 6-10-2022 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392

Guest: Alan Ehrlich MD, FAAFP

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation. 

Episode resource links:

• Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217

Guest: Jillian Joseph, MSPAS, PA-C

Credits: 0.25 AMA PRA Category 1 Credit™

CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/multi-cancer-early-detection

Overview:

Carve out 15 minutes in your day to listen to an expert-led podcast on the current landscape of cancer screening and how emerging technology in multi-cancer early detection (MCED) screening tests will likely improve this landscape. Listen while experts define this new technology, explain how it works, and discuss its benefits and limitations. Find out how available and emerging MCED tests can augment your current screening strategies and optimize cancer detection, potentially catching a greater number of early-stage cancers and saving lives.

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Statins are widely used for lowering cholesterol in patients at risk for cardiovascular disease. While the benefit is more established with secondary prevention compared with primary prevention, most of the benefits are reported in relative risk reduction, which can exaggerate the benefit to an individual person. In this podcast, you’ll hear a discussion of a recent systematic review that looked at the absolute risk reduction and relative risk reduction with statins for preventing death, myocardial infarctions, and stroke.

Episode resource links:

• Byrne, P. , Demasi, M. , Jones, M. , et al. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine

Guest: Alan Ehrlich MD, FAAFP

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Clinicians (and patients) know that walking is beneficial for overall health, but what are the specifics? How many steps per day lower health risks? What impact does walking have on mortality? What’s the best way to count steps? Join us to hear answers to these questions and more as we discuss evidence-based recommendations for steps/day.

Episode resource links:

Paluch, A. E., Bajpai, S., Bassett, D. R., Carnethon, M. R., Ekelund, U., Evenson, K. R., Galuska, D. A., Jefferis, B. J., Kraus, W. E., Lee, I. M., Matthews, C. E., Omura, J. D., Patel, A. V., Pieper, C. F., Rees-Punia, E., Dallmeier, D., Klenk, J., Whincup, P. H., Dooley, E. E., Pettee Gabriel, K., … Steps for Health Collaborative (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet. Public health, 7(3), e219–e228. https://doi.org/10.1016/S2468-2667(21)00302-9  

https://www.cdc.gov/physicalactivity/index.html This website includes data, resources and information for patients and providers for physical activity.

Guest: Jill M. Terrien PhD, ANP-BC